JD Supra

Part II: Does Your Patent Office Post-Grant Strategy Account for the Rise of Serial Challenges Flowing From the PTAB to the CRU?

In a March 2025 article, we provided strategy considerations for both parties handling ex parte reexaminations following denied inter partes ...
eLife

Structure-based Design of Chimeric Influenza Hemagglutinins to Elicit Cross-group Immunity

This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...